<DOC>
	<DOC>NCT01085006</DOC>
	<brief_summary>Intravenous Tranexamic acid is used to reduce the hemorrhage during and after cesarean delivery in a double blind randomized placebo controlled trial.</brief_summary>
	<brief_title>The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1. Term pregnancy 2. Single fetus 3. Maximally only one previous cesarean delivery 1. More than one previous cesarean delivery 2. Hx of other abdominal or pelvic surgery 3. Hx of medical disorders 4. Hx of thromboembolic disorders 5. Polyhydramnios 6. Macrosomia 7. Preeclampsia 8. Hx of sensitivity to Tranexamic acid 9. Abnormal Pt, PTT, PT or INR</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>cesarean delivery</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>Spinal analgesia</keyword>
	<keyword>1-the amount of hemorrhage during cesarean delivery</keyword>
	<keyword>2-the amount of hemorrhage in the first 2 hours of cesarean delivery</keyword>
	<keyword>3-the amount of hemorrhage in the first 24 hour after cesarean delivery</keyword>
</DOC>